Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
Trip.com Group
TCOM
|
$575M |
| 2 |
DexCom
DXCM
|
$491M |
| 3 |
NVIDIA
NVDA
|
$346M |
| 4 |
ResMed
RMD
|
$334M |
| 5 |
MBLY
Mobileye N.V.
MBLY
|
$282M |
Top Sells
| 1 |
WFM
Whole Foods Market Inc
WFM
|
$281M |
| 2 |
American Express
AXP
|
$255M |
| 3 |
LNKD
LinkedIn Corporation
LNKD
|
$162M |
| 4 |
Stellantis
STLA
|
$113M |
| 5 |
Ryanair
RYAAY
|
$68.8M |
Sector Composition
| 1 | Consumer Discretionary | 35.19% |
| 2 | Communication Services | 18.4% |
| 3 | Healthcare | 14.19% |
| 4 | Financials | 8.31% |
| 5 | Technology | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
PACCAR
PCAR
$51.1B
| $10.8M | 0.02% |
276,371
| – | – |
|
152
Donaldson
DCI
$9.32B
| $10.8M | 0.02% |
290,081
| – | – |
|
|
AFT
153
DELISTED
Apollo Senior Floating Rate Fund Inc.
AFT
| $10.5M | 0.02% |
617,746
| – | – |
|
154
WEC Energy
WEC
$34.5B
| $10.4M | 0.02% |
174,130
+130
| +0.1% | +$7.78K |
|
|
VAR
155
DELISTED
Varian Medical Systems, Inc.
VAR
| $10M | 0.02% |
114,799
| – | – |
|
156
Bristol-Myers Squibb
BMY
$95B
| $9.91M | 0.02% |
183,785
| – | – |
|
157
Estee Lauder
EL
$31.8B
| $9.88M | 0.02% |
111,584
| – | – |
|
158
Philip Morris
PM
$250B
| $9.73M | 0.02% |
100,072
-29,498
| -23% | -$2.87M |
|
159
Schlumberger
SLB
$53.6B
| $9.37M | 0.01% |
119,127
| – | – |
|
160
American Water Works
AWK
$27.5B
| $9.14M | 0.01% |
122,159
| – | – |
|
161
Sherwin-Williams
SHW
$91.4B
| $8.64M | 0.01% |
93,708
| – | – |
|
162
Stratasys
SSYS
$858M
| $8.58M | 0.01% |
356,100
| – | – |
|
|
PX
163
DELISTED
Praxair Inc
PX
| $8.49M | 0.01% |
70,221
-22,063
| -24% | -$2.67M |
|
|
NVDQ
164
DELISTED
Novadaq Technologies Inc.
NVDQ
| $8.15M | 0.01% |
704,480
| – | – |
|
|
ELLI
165
DELISTED
Ellie Mae Inc
ELLI
| $7.48M | 0.01% |
71,000
| – | – |
|
|
CSLT
166
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $7.47M | 0.01% |
1,794,820
| – | – |
|
167
Pacira BioSciences
PCRX
$1.2B
| $7.31M | 0.01% |
213,600
| – | – |
|
168
AeroVironment
AVAV
$11.2B
| $7.02M | 0.01% |
287,710
+59,000
| +26% | +$1.44M |
|
|
EXA
169
DELISTED
EXA Corporation
EXA
| $6.74M | 0.01% |
419,630
| – | – |
|
170
Digimarc
DMRC
$175M
| $6.69M | 0.01% |
174,500
| – | – |
|
|
STMP
171
DELISTED
Stamps.com, Inc.
STMP
| $6.54M | 0.01% |
69,150
-45,000
| -39% | -$4.25M |
|
|
ADAP
172
Adaptimmune Therapeutics
ADAP
$13.1M
| $6.49M | 0.01% |
920,984
+491,284
| +114% | +$3.46M |
|
|
FARO
173
DELISTED
Faro Technologies
FARO
| $6.26M | 0.01% |
174,080
+50,000
| +40% | +$1.8M |
|
174
Trupanion
TRUP
$1.93B
| $6.23M | 0.01% |
+368,364
| New | +$6.23M |
|
|
SCTY
175
DELISTED
SolarCity Corporation
SCTY
| $6.12M | 0.01% |
312,900
| – | – |
|